Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219

1.

Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study.

Presotto EM, Rastrelli G, Desideri I, Scotti V, Gunnella S, Pimpinelli N, Vaccher E, Bearz A, Di Costanzo F, Bruggia M, Mini E, Maggi M, Peri A.

J Endocrinol Invest. 2019 Sep 21. doi: 10.1007/s40618-019-01112-8. [Epub ahead of print]

PMID:
31542865
2.

Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Advanced Thyroid Cancer.

Vaccher E, Schioppa O, Martellotta F, Fornasier G, Giacomin E, Lo Re F, Baldo P, Corona G, Gobitti C.

Recent Pat Anticancer Drug Discov. 2019 Jul 26. doi: 10.2174/1574892814666190726143011. [Epub ahead of print]

PMID:
31362663
3.

Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma.

De Re V, Tornesello ML, De Zorzi M, Caggiari L, Pezzuto F, Leone P, Racanelli V, Lauletta G, Gragnani L, Buonadonna A, Vaccher E, Zignego AL, Steffan A, Buonaguro FM.

Front Microbiol. 2019 Mar 15;10:475. doi: 10.3389/fmicb.2019.00475. eCollection 2019.

4.

Direct health-care cost of head and neck cancers: a population-based study in north-eastern Italy.

Polesel J, Lupato V, Collarile P, Vaccher E, Fanetti G, Giacomarra V, Palazzari E, Furlan C, Matrone F, Navarria F, Gobitti C, Minatel E, Serraino D, Birri S, Franchin G.

Med Oncol. 2019 Feb 28;36(4):31. doi: 10.1007/s12032-019-1256-2.

PMID:
30815763
5.

Bright-field in situ hybridization detects gene alterations and viral infections useful for personalized management of cancer patients.

Volpi CC, Gualeni AV, Pietrantonio F, Vaccher E, Carbone A, Gloghini A.

Expert Rev Mol Diagn. 2018 Mar;18(3):259-277. doi: 10.1080/14737159.2018.1440210. Epub 2018 Feb 21. Review.

PMID:
29431533
6.

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Bossi P, Miceli R, Locati LD, Ferrari D, Vecchio S, Moretti G, Denaro N, Caponigro F, Airoldi M, Moro C, Vaccher E, Sponghini A, Caldara A, Rinaldi G, Ferrau F, Nolè F, Lo Vullo S, Tettamanzi F, Hollander L, Licitra L.

Ann Oncol. 2017 Nov 1;28(11):2820-2826. doi: 10.1093/annonc/mdx439.

PMID:
28950305
7.

Prognostic significance of LINE-1 hypomethylation in oropharyngeal squamous cell carcinoma.

Furlan C, Polesel J, Barzan L, Franchin G, Sulfaro S, Romeo S, Colizzi F, Rizzo A, Baggio V, Giacomarra V, Dei Tos AP, Boscolo-Rizzo P, Vaccher E, Dolcetti R, Sigalotti L, Fratta E.

Clin Epigenetics. 2017 May 30;9:58. doi: 10.1186/s13148-017-0357-z. eCollection 2017.

8.

The impact of time to treatment initiation on survival from head and neck cancer in north-eastern Italy.

Polesel J, Furlan C, Birri S, Giacomarra V, Vaccher E, Grando G, Gobitti C, Navarria F, Schioppa O, Minatel E, Bidoli E, Barzan L, Franchin G.

Oral Oncol. 2017 Apr;67:175-182. doi: 10.1016/j.oraloncology.2017.02.009. Epub 2017 Mar 3.

PMID:
28351574
9.

An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma.

Citron F, Armenia J, Franchin G, Polesel J, Talamini R, D'Andrea S, Sulfaro S, Croce CM, Klement W, Otasek D, Pastrello C, Tokar T, Jurisica I, French D, Bomben R, Vaccher E, Serraino D, Belletti B, Vecchione A, Barzan L, Baldassarre G.

Clin Cancer Res. 2017 Jul 15;23(14):3769-3780. doi: 10.1158/1078-0432.CCR-16-2814. Epub 2017 Feb 7.

10.

Multiple preinvasive and invasive HPV-related lesions of the anogenital tract in a female patient with HIV infection: A case report.

Clemente N, Alessandrini L, Vaccher E, De Paoli A, Buttignol M, Canzonieri V, Sopracordevole F.

Medicine (Baltimore). 2017 Jan;96(4):e5948. doi: 10.1097/MD.0000000000005948.

11.

HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2.

De Re V, De Zorzi M, Caggiari L, Lauletta G, Tornesello ML, Fognani E, Miorin M, Racanelli V, Quartuccio L, Gragnani L, Russi S, Pavone F, Ghersetti M, Costa EG, Casarin P, Bomben R, Mazzaro C, Basaglia G, Berretta M, Vaccher E, Izzo F, Buonaguro FM, De Vita S, Zignego AL, De Paoli P, Dolcetti R.

Oncotarget. 2016 Jun 21;7(25):37487-37497. doi: 10.18632/oncotarget.9303.

12.

Broadening Specificity and Enhancing Cytotoxicity of Adoptive T Cells for Nasopharyngeal Carcinoma Immunotherapy.

Faè DA, Martorelli D, Mastorci K, Muraro E, Dal Col J, Franchin G, Barzan L, Comaro E, Vaccher E, Rosato A, Dolcetti R.

Cancer Immunol Res. 2016 May;4(5):431-40. doi: 10.1158/2326-6066.CIR-15-0108. Epub 2016 Mar 23.

13.

Efficacy of paclitaxel in the treatment of Kaposi sarcoma.

Martellotta F, Schioppa O, Vaccher E.

Eur Rev Med Pharmacol Sci. 2015 Dec;19(24):4681-3. No abstract available.

14.

Specific Antibodies Reacting with SV40 Large T Antigen Mimotopes in Serum Samples of Healthy Subjects.

Tognon M, Corallini A, Manfrini M, Taronna A, Butel JS, Pietrobon S, Trevisiol L, Bononi I, Vaccher E, Barbanti-Brodano G, Martini F, Mazzoni E.

PLoS One. 2016 Jan 5;11(1):e0145720. doi: 10.1371/journal.pone.0145720. eCollection 2016.

15.

Clinical presentation and outcome of non-AIDS defining cancers, in HIV-infected patients in the ART-era: the Italian Cooperative Group on AIDS and tumors activity.

Berretta M, Martellotta F, Di Francia R, Spina M, Vaccher E, Balestreri L, Borsatti E, Bearz A, De Paoli P, Tirelli U.

Eur Rev Med Pharmacol Sci. 2015 Oct;19(19):3619-34.

16.

Lower platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma: a retrospective analysis.

Furlan C, Steffan A, Polesel J, Trovo M, Gobitti C, Vaccher E, Serraino D, Barzan L, Franchin G.

Biomark Res. 2015 Oct 6;3:25. doi: 10.1186/s40364-015-0051-2. eCollection 2015.

17.

Plasma biomarkers of clinical response during chemotherapy plus combination antiretroviral therapy (cART) in HIV+ patients with advanced Kaposi sarcoma.

Tedeschi R, Bidoli E, Bortolin MT, Schioppa O, Vaccher E, De Paoli P.

Oncotarget. 2015 Oct 6;6(30):30334-42. doi: 10.18632/oncotarget.4571.

18.

Correction: Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases.

De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Vaccher E, Beretta M, Mazzaro C, Libra M, Gini A, Zucchetto A, Cannizzaro R, De Paoli P.

PLoS One. 2015 May 15;10(5):e0128849. doi: 10.1371/journal.pone.0128849. eCollection 2015. No abstract available.

19.

Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases.

De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Vaccher E, Berretta M, Mazzaro C, Libra M, Gini A, Zucchetto A, Cannizzaro R, De Paoli P.

PLoS One. 2015 Feb 20;10(2):e0117420. doi: 10.1371/journal.pone.0117420. eCollection 2015. Erratum in: PLoS One. 2015;10(5):e0128849. Beretta, Massimiliano [corrected to Berretta, Massimiliano].

20.

Autograft HIV-DNA load predicts HIV-1 peripheral reservoir after stem cell transplantation for AIDS-related lymphoma patients.

Zanussi S, Bortolin MT, Pratesi C, Tedeschi R, Basaglia G, Abbruzzese L, Mazzucato M, Spina M, Vaccher E, Tirelli U, Rupolo M, Michieli M, Di Mascio M, De Paoli P.

AIDS Res Hum Retroviruses. 2015 Jan;31(1):150-9. doi: 10.1089/aid.2014.0157.

21.

Serologic investigation of undifferentiated nasopharyngeal carcinoma and simian virus 40 infection.

Mazzoni E, Martini F, Corallini A, Taronna A, Barbanti-Brodano G, Querzoli P, Magri E, Rotondo JC, Dolcetti R, Vaccher E, Tognon M.

Head Neck. 2016 Feb;38(2):232-6. doi: 10.1002/hed.23879. Epub 2015 Jun 16.

PMID:
25244358
22.

The evolving scenario of non-AIDS-defining cancers: challenges and opportunities of care.

Vaccher E, Serraino D, Carbone A, De Paoli P.

Oncologist. 2014 Aug;19(8):860-7. doi: 10.1634/theoncologist.2014-0024. Epub 2014 Jun 26. Review.

23.

Head and neck cancer survivors patients and late effects related to oncologic treatment: update of literature.

Taibi R, Lleshi A, Barzan L, Fiorica F, Leghissa M, Vaccher E, De Paoli P, Franchin G, Berretta M, Tirelli U.

Eur Rev Med Pharmacol Sci. 2014;18(10):1473-81. Review.

24.

KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.

Carbone A, De Paoli P, Gloghini A, Vaccher E.

Int J Cancer. 2015 Jul 15;137(2):251-61. doi: 10.1002/ijc.28923. Epub 2014 May 5. Review.

25.

Diagnosis and management of lymphomas and other cancers in HIV-infected patients.

Carbone A, Vaccher E, Gloghini A, Pantanowitz L, Abayomi A, de Paoli P, Franceschi S.

Nat Rev Clin Oncol. 2014 Apr;11(4):223-38. doi: 10.1038/nrclinonc.2014.31. Epub 2014 Mar 11. Review.

PMID:
24614140
26.

Lung cancer in HIV positive patients: the GICAT experience.

Bearz A, Vaccher E, Martellotta F, Spina M, Talamini R, Lleshi A, Cacopardo B, Nunnari G, Berretta M, Tirelli U; Italian Cooperative Group on AIDS and Tumors.

Eur Rev Med Pharmacol Sci. 2014;18(4):500-8.

27.

Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk.

Lestuzzi C, Vaccher E, Talamini R, Lleshi A, Meneguzzo N, Viel E, Scalone S, Tartuferi L, Buonadonna A, Ejiofor L, Schmoll HJ.

Ann Oncol. 2014 May;25(5):1059-64. doi: 10.1093/annonc/mdu055. Epub 2014 Feb 20.

PMID:
24558023
28.

Life expectancy in the immune recovery era: the evolving scenario of the HIV epidemic in northern Italy.

Guaraldi G, Cossarizza A, Franceschi C, Roverato A, Vaccher E, Tambussi G, Garlassi E, Menozzi M, Mussini C, Dʼarminio Monforte A.

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):175-81. doi: 10.1097/QAI.0000000000000018.

PMID:
24442223
29.

Potential hazard drug-drug interaction between boosted protease inhibitors and vinblastine in HIV patients with Hodgkin's lymphoma.

Corona G, Vaccher E, Spina M, Toffoli G.

AIDS. 2013 Mar 27;27(6):1033-5. doi: 10.1097/QAD.0b013e32835e0777. No abstract available.

PMID:
23698067
30.

Consumption of fruit, vegetables, and other food groups and the risk of nasopharyngeal carcinoma.

Polesel J, Serraino D, Negri E, Barzan L, Vaccher E, Montella M, Zucchetto A, Garavello W, Franceschi S, La Vecchia C, Talamini R.

Cancer Causes Control. 2013 Jun;24(6):1157-65. doi: 10.1007/s10552-013-0195-z. Epub 2013 Mar 28.

PMID:
23535867
31.

Multiplex analysis of blood cytokines as a prognostic tool in HIV related non-Hodgkin lymphoma patients: a potential role of interleukin-7.

Bortolin MT, Tedeschi R, Bidoli E, Zanussi S, Pratesi C, Vaccher E, Tirelli U, De Paoli P.

Cytokine. 2012 Oct;60(1):90-5. doi: 10.1016/j.cyto.2012.06.022. Epub 2012 Jul 12.

PMID:
22795293
32.

Comment on 'Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection'.

Bearz A, Vaccher E, Talamini R, Berretta M, Tirelli U.

Br J Cancer. 2012 May 22;106(11):1899-900. doi: 10.1038/bjc.2012.181. Epub 2012 May 3. No abstract available.

33.

Assessment of immunovirological features in HIV related non-Hodgkin lymphoma patients and their impact on outcome.

Tedeschi R, Bortolin MT, Bidoli E, Zanussi S, Pratesi C, Vaccher E, Tirelli U, De Paoli P.

J Clin Virol. 2012 Apr;53(4):297-301. doi: 10.1016/j.jcv.2011.12.021. Epub 2012 Jan 11.

PMID:
22244256
34.

Pemetrexed as second-line chemotherapy for castration-resistant prostate cancer after docetaxel failure: results from a phase II study.

Caffo O, Fratino L, Barbieri R, Perin A, Martini T, Sava T, Segati R, Vaccher E, Bernardo Bassan F, Veccia A, Pappagallo G, Galligioni E.

Urol Oncol. 2013 Feb;31(2):180-6. doi: 10.1016/j.urolonc.2010.11.012. Epub 2011 Jul 31.

PMID:
21803618
35.

Intensity-modulated radiotherapy (IMRT)/Tomotherapy following neoadjuvant chemotherapy in stage IIB-IVA/B undifferentiated nasopharyngeal carcinomas (UCNT): a mono-institutional experience.

Franchin G, Vaccher E, Talamini R, Politi D, Gobitti C, Minatel E, Lleshi A, Sartor G, Mascarin M, Rumeileh IA, Trovò MG, Barzan L.

Oral Oncol. 2011 Sep;47(9):905-9. doi: 10.1016/j.oraloncology.2011.06.503. Epub 2011 Jul 23.

PMID:
21783403
36.

Tobacco smoking, alcohol drinking, and the risk of different histological types of nasopharyngeal cancer in a low-risk population.

Polesel J, Franceschi S, Talamini R, Negri E, Barzan L, Montella M, Libra M, Vaccher E, Franchin G, La Vecchia C, Serraino D.

Oral Oncol. 2011 Jun;47(6):541-5. doi: 10.1016/j.oraloncology.2011.03.017. Epub 2011 Apr 7.

PMID:
21478046
37.

Alteration of G1/S transition regulators influences recurrences in head and neck squamous carcinomas.

Canzonieri V, Barzan L, Franchin G, Vaccher E, Talamini R, Sulfaro S, Baldassarre G.

J Cell Physiol. 2012 Jan;227(1):233-8. doi: 10.1002/jcp.22723.

PMID:
21412768
38.

Immune recovery after autologous stem cell transplantation is not different for HIV-infected versus HIV-uninfected patients with relapsed or refractory lymphoma.

Simonelli C, Zanussi S, Pratesi C, Rupolo M, Talamini R, Caffau C, Teresa Bortolin M, Tedeschi R, Basaglia G, Mazzucato M, Manuele R, Vaccher E, Spina M, Tirelli U, Michieli M, De Paoli P.

Clin Infect Dis. 2010 Jun 15;50(12):1672-9. doi: 10.1086/652866.

PMID:
20450419
39.

Phase 2 study of intrathecal, long-acting liposomal cytarabine in the prophylaxis of lymphomatous meningitis in human immunodeficiency virus-related non-Hodgkin lymphoma.

Spina M, Chimienti E, Martellotta F, Vaccher E, Berretta M, Zanet E, Lleshi A, Canzonieri V, Bulian P, Tirelli U.

Cancer. 2010 Mar 15;116(6):1495-501. doi: 10.1002/cncr.24922.

40.

AIDS-related Kaposi's sarcoma: state of the art and therapeutic strategies.

Martellotta F, Berretta M, Vaccher E, Schioppa O, Zanet E, Tirelli U.

Curr HIV Res. 2009 Nov;7(6):634-8. Review.

PMID:
19929800
41.

Management of immunocompetent patients with primary central nervous system lymphoma.

Chimienti E, Spina M, Vaccher E, Tirelli U.

Clin Lymphoma Myeloma. 2009 Oct;9(5):353-64. doi: 10.3816/CLM.2009.n.070. Review.

PMID:
19858054
42.

Undifferentiated nasopharyngeal carcinoma from a nonendemic area: protective role of HLA allele products presenting conserved EBV epitopes.

Pasini E, Caggiari L, Dal Maso L, Martorelli D, Guidoboni M, Vaccher E, Barzan L, Franchin G, Gloghini A, De Re V, Sacchi N, Serraino D, Carbone A, Rosato A, Dolcetti R.

Int J Cancer. 2009 Sep 15;125(6):1358-64. doi: 10.1002/ijc.24515.

43.

High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors.

Re A, Michieli M, Casari S, Allione B, Cattaneo C, Rupolo M, Spina M, Manuele R, Vaccher E, Mazzucato M, Abbruzzese L, Ferremi P, Carosi G, Tirelli U, Rossi G.

Blood. 2009 Aug 13;114(7):1306-13. doi: 10.1182/blood-2009-02-202762. Epub 2009 May 18.

PMID:
19451551
44.

Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.

Simonelli C, Tedeschi R, Gloghini A, Talamini R, Bortolin MT, Berretta M, Spina M, Morassut S, Vaccher E, De Paoli P, Carbone A, Tirelli U.

J Med Virol. 2009 May;81(5):888-96. doi: 10.1002/jmv.21349.

PMID:
19319955
45.

Postoperative reduced dose of cisplatin concomitant with radiation therapy in high- risk head and neck squamous cell carcinoma.

Franchin G, Minatel E, Politi D, Gobitti C, Talamini R, Vaccher E, Savignano MG, Trovo M, Sulfaro S, Barzan L.

Cancer. 2009 Jun 1;115(11):2464-71. doi: 10.1002/cncr.24252.

46.

Organ preservation in locally advanced head and neck cancer of the larynx using induction chemotherapy followed by improved radiation schemes.

Franchin G, Vaccher E, Politi D, Minatel E, Gobitti C, Talamini R, Spazzapan S, Savignano MG, Trovò MG, Barzan L.

Eur Arch Otorhinolaryngol. 2009 May;266(5):719-26. doi: 10.1007/s00405-008-0798-2. Epub 2008 Sep 9.

PMID:
18779973
47.

Spontaneous T cell responses to Epstein-Barr virus-encoded BARF1 protein and derived peptides in patients with nasopharyngeal carcinoma: bases for improved immunotherapy.

Martorelli D, Houali K, Caggiari L, Vaccher E, Barzan L, Franchin G, Gloghini A, Pavan A, Da Ponte A, Tedeschi RM, De Re V, Carbone A, Ooka T, De Paoli P, Dolcetti R.

Int J Cancer. 2008 Sep 1;123(5):1100-7. doi: 10.1002/ijc.23621.

48.

Rapid and sensitive analysis of vincristine in human plasma using on-line extraction combined with liquid chromatography/tandem mass spectrometry.

Corona G, Casetta B, Sandron S, Vaccher E, Toffoli G.

Rapid Commun Mass Spectrom. 2008;22(4):519-25. doi: 10.1002/rcm.3390.

PMID:
18228243
49.

MUC-1 (CA 15-3 antigen) as a highly reliable predictor of response to EGFR inhibitors in patients with bronchioloalveolar carcinoma: an experience on 26 patients.

Bearz A, Talamini R, Vaccher E, Spina M, Simonelli C, Steffan A, Berretta M, Chimienti E, Tirelli U.

Int J Biol Markers. 2007 Oct-Dec;22(4):307-11.

PMID:
18161663
50.

Lopinavir-ritonavir dramatically affects the pharmacokinetics of irinotecan in HIV patients with Kaposi's sarcoma.

Corona G, Vaccher E, Sandron S, Sartor I, Tirelli U, Innocenti F, Toffoli G.

Clin Pharmacol Ther. 2008 Apr;83(4):601-6. Epub 2007 Aug 22.

PMID:
17713471

Supplemental Content

Loading ...
Support Center